Clearside Biomedical's total assets for Q3 2025 were $11.64M, a decrease of -24.07% from the previous quarter. CLSD total liabilities were $65.59M for the fiscal quarter, a 2.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.